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Summary 
 
In the thesis I present the collected evidences that we successfully combined 
the modified surgical bipolar forceps and ultrasonic aspirator with a mobile mass 
spectrometer. In this manner we created a tool not only for real time but also for in 
situ tissue analysis. Moreover this method has the fundamental advantage of mass 
spectrometry by analysing the molecular constitution of tissues. This kind of 
molecular description may open further gates to compare the mass spectrum with the 
presence of classic genetic and immunehistochemic markers.   
In our experiments with the bipolar forceps and the ultrasound aspirator we 
have revealed that the discrimination between tumorous and healthy neural tissues is 
possible. Both instruments were successfully coupled to neuronavigation. These 
possibilities, especially the ultrasound based method significantly could help the 
neurosurgeon who operates gliomas or glioblastoma by improving the extent of safe 
resection. 
Our experiments proved if an appropriate database is available, fast and 
intraoperative histology can be obtained by both of our instruments and even grade 
level histologic discrimination can be performed. The real time tissue analysis can be 
useful in the analysis of rare, macroscopically unidentifiable tumors, especially when 
the operated tumour needs different treatment strategy in the aware of the histology. 
Therefore in this thesis we showed that retrospective analysis of a rare entity could 
reveal the importance of real-time intra-operative histology. 
Moreover in this thesis I presented our expression results of GHRH, 
pGHRHR, its splicing variants, PTEN and EGFR genes in human glioblastoma 
samples. Our study provides the first evidence that GHRH and SV1 are present in a 
substantial part of human GB tissues. We pointed out that expression pattern of 
GHRH and its SV1 receptors could predict prognosis. Namely GHRH positive, SV1 
negative cases showed better overall survival. These results showed that we have 
moved towards finding the GHRH pathway suitable as a molecular target and a useful 
prognostic factor in human glioblastomas.  
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